Items where the Publication is The lancet. HIV
Number of items: 16.
C
Disparities in breast cancer survival between women with and without HIV across sub-Saharan Africa (ABC-DO): a prospective, cohort study. (2022)
Chasimpha, Steady; McCormack, Valerie; Cubasch, Herbert; Joffe, Maureen; Zietsman, Annelle; Galukande, Moses; Parham, Groesbeck; Pinder, Leeya F; Anele, Angelica; Adisa, Charles A; Offiah, Awa Ukonye; Anderson, Benjamin O; Boucheron, Pauline; Foerster, Milena; Schüz, Joachim; Dos-Santos-Silva, Isabel
D
The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis. (2021)
Dorward, Jienchi; Khubone, Thokozani; Gate, Kelly; Ngobese, Hope; Sookrajh, Yukteshwar; Mkhize, Siyabonga; Jeewa, Aslam; Bottomley, Christian; Lewis, Lara; Baisley, Kathy; Butler, Christopher C; Gxagxisa, Nomakhosi; Garrett, Nigel
G
Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. (2019)
GBD 2017 HIV collaborators
Trends in knowledge of HIV status and efficiency of HIV testing services in sub-Saharan Africa, 2000-20: a modelling study using survey and HIV testing programme data. (2021)
Giguère, Katia; Eaton, Jeffrey W; Marsh, Kimberly; Johnson, Leigh F; Johnson, Cheryl C; Ehui, Eboi; Jahn, Andreas; Wanyeki, Ian; Mbofana, Francisco; Bakiono, Fidèle; Mahy, Mary; Maheu-Giroux, Mathieu
L
Rates of viral suppression in a cohort of people with stable HIV from two community models of ART delivery versus facility-based HIV care in Lusaka, Zambia: a cluster-randomised, non-inferiority trial nested in the HPTN 071 (PopART) trial. (2022)
Limbada, Mohammed; Macleod, David; Situmbeko, Vasty; Muhau, Ellen; Shibwela, Osborn; Chiti, Bwalya; Floyd, Sian; Schaap, Albertus J; Hayes, Richard; Fidler, Sarah; Ayles, Helen; HPTN 071 (PopART) study team
Subnational mapping of HIV incidence and mortality among individuals aged 15-49 years in sub-Saharan Africa, 2000-18: a modelling study. (2021)
Local Burden of Disease HIV Collaborators
M
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial. (2021)
Madhi, Shabir A; Koen, Anthonet L; Izu, Alane; Fairlie, Lee; Cutland, Clare L; Baillie, Vicky; Padayachee, Sherman D; Dheda, Keertan; Barnabas, Shaun L; Bhorat, Qasim Ebrahim; Briner, Carmen; Aley, Parvinder K; Bhikha, Sutika; Hermanus, Tandile; Horne, Elizea; Jose, Aylin; Kgagudi, Prudence; Lambe, Teresa; Masenya, Masebole; Masilela, Mduduzi; Mkhize, Nonhlanhla; Moultrie, Andrew; Mukendi, Christian K; Moyo-Gwete, Thandeka; Nana, Amit J; Nzimande, Ayanda; Patel, Faeezah; Rhead, Sarah; Taoushanis, Carol; Thombrayil, Asha; van Eck, Samuel; Voysey, Merryn; Villafana, Tonya L; Vekemans, Johan; Gilbert, Sarah C; Pollard, Andrew J; Moore, Penny L; Kwatra, Gaurav; Wits VIDA COVID team
Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial. (2022)
Madhi, Shabir A; Moodley, Dhayendre; Hanley, Sherika; Archary, Moherndran; Hoosain, Zaheer; Lalloo, Umesh; Louw, Cheryl; Fairlie, Lee; Fouche, Leon Frederik; Masilela, Mduduzi SL; Singh, Nishanta; Grobbelaar, Coert; Ahmed, Khatija; Benadé, Gabriella; Bhikha, Sutika; Bhorat, As'ad Ebrahim; Bhorat, Qasim; Joseph, Natasha; Dheda, Keertan; Esmail, Aliasgar; Foulkes, Sharne; Goga, Ameena; Oommen Jose, Aylin; Kruger, Gertruida; Kalonji, Dishiki J; Lalloo, Natasha; Lombaard, Johan J; Lombard Koen, Anthonet; Kany Luabeya, Angelique; Mngqibisa, Rosie; Petrick, Friedrich G; Pitsi, Annah; Tameris, Michele; Thombrayil, Asha; Vollgraaff, Pieter-Louis; Cloney-Clark, Shane; Zhu, Mingzhu; Bennett, Chijioke; Albert, Gary; Faust, Emmanuel; Plested, Joyce S; Fries, Lou; Robertson, Andreana; Neal, Susan; Cho, Iksung; Glenn, Greg M; Shinde, Vivek; 2019nCoV-501 Study Group
Factors associated with HIV infection among children in Larkana District, Pakistan: a matched case-control study. (2021)
Mir, Fatima; Nathwani, Apsara Ali; Simms, Victoria; Abidi, Syed Hani; Siddiqui, Amna Rehana; Hotwani, Aneeta; Memon, Sikander Ali; Shaikh, Saqib Ali; Soomro, Jamila; Shah, Sharaf Ali; Achakzai, Baseer; Furqan, Sofia; Saeed, Quaid; Khan, Palwasha; Weiss, Helen A; Mahmood, Syed Faisal; Ferrand, Rashida Abbas
P
Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial. (2022)
Paton, Nicholas I; Musaazi, Joseph; Kityo, Cissy; Walimbwa, Stephen; Hoppe, Anne; Balyegisawa, Apolo; Asienzo, Jesca; Kaimal, Arvind; Mirembe, Grace; Lugemwa, Abbas; Ategeka, Gilbert; Borok, Margaret; Mugerwa, Henry; Siika, Abraham; Odongpiny, Eva Laker A; Castelnuovo, Barbara; Kiragga, Agnes; Kambugu, Andrew; NADIA Trial Team
Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa (the HPTN 071 [PopART] trial): a modelling study. (2022)
Probert, William JM; Sauter, Rafael; Pickles, Michael; Cori, Anne; Bell-Mandla, Nomtha F; Bwalya, Justin; Abeler-Dörner, Lucie; Bock, Peter; Donnell, Deborah J; Floyd, Sian; Macleod, David; Piwowar-Manning, Estelle; Skalland, Timothy; Shanaube, Kwame; Wilson, Ethan; Yang, Blia; Ayles, Helen; Fidler, Sarah; Hayes, Richard J; Fraser, Christophe; HPTN 071 (PopART) Study Team
R
Age patterns of HIV incidence in eastern and southern Africa: a modelling analysis of observational population-based cohort studies. (2021)
Risher, Kathryn A; Cori, Anne; Reniers, Georges; Marston, Milly; Calvert, Clara; Crampin, Amelia; Dadirai, Tawanda; Dube, Albert; Gregson, Simon; Herbst, Kobus; Lutalo, Tom; Moorhouse, Louisa; Mtenga, Baltazar; Nabukalu, Dorean; Newton, Robert; Price, Alison J; Tlhajoane, Malebogo; Todd, Jim; Tomlin, Keith; Urassa, Mark; Vandormael, Alain; Fraser, Christophe; Slaymaker, Emma; Eaton, Jeffrey W; ALPHA Network
W
Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial. (2022)
Waalewijn, Hylke; Chan, Man K; Bollen, Pauline DJ; Mujuru, Hilda A; Makumbi, Shafic; Kekitiinwa, Adeodata R; Kaudha, Elizabeth; Sarfati, Tatiana; Musoro, Godfrey; Nanduudu, Annet; Lugemwa, Abbas; Amuge, Pauline; Moore, Cecilia L; Rojo, Pablo; Giaquinto, Carlo; Colbers, Angela; Gibb, Diana M; Ford, Deborah; Turkova, Anna; Burger, David M; ODYSSEY Trial Team
Correction to Lancet HIV 2016; 3: e361-87. (2016)
Wang, H; Wolock, TM; Carter, A; Nguyen, G; Kyu, HH; Gakidou, E; Hay, SI; Mills, EJ; Trickey, A; Msemburi, W; Coates, MM; Mooney, MD; Fraser, MS; Sligar, A; Salomon, J; Larson, HJ; Friedman, J; Abajobir, AA; Abate, KH; Abbas, KM; Razek, MMAE; Abd-Allah, F; Abdulle, AM; Abera, SF; Abubakar, I; Abu-Raddad, LJ; Abu-Rmeileh, NME; Abyu, GY; Adebiyi, AO; Adedeji, IA; Adelekan, AL; Adofo, K; Adou, AK; Ajala, ON; Akinyemiju, TF; Akseer, N; Lami, FHA; Al-Aly, Z; Alam, K; Alam, NKM; Alasfoor, D; Aldhahri, SFS; Aldridge, RW; Alegretti, MA; Aleman, AV; Alemu, ZA; Alfonso-Cristancho, R; Ali, R; Alkerwi, A; Alla, F; Mohammad, R; Al-Raddadi, S; Alsharif, U; Alvarez, E; Alvis-Guzman, N; Amare, AT; Amberbir, A; Amegah, AK; Ammar, W; Amrock, SM; Antonio, CAT; Anwari, P; Ärnlöv, J; Artaman, A; Asayesh, H; Asghar, RJ; Assadi, R; Atique, S; Atkins, LS; Avokpaho, EFGA; Awasthi, A; Quintanilla, BPA; Bacha, U; Badawi, A; Barac, A; Bärnighausen, T; Basu, A; Bayou, TA; Bayou, YT; Bazargan-Hejazi, S; Beardsley, J; Bedi, N; Bennett, DA; Bensenor, IM; Betsu, BD; Beyene, AS; Bhatia, E; Bhutta, ZA; Biadgilign, S; Bikbov, B; Birlik, SM; Bisanzio, D; Brainin, M; Brazinova, A; Breitborde, NJK; Brown, A; Burch, M; Butt, ZA; Campuzano, JC; Cárdenas, R
